1. Home
  2. MTSR
  3. MTSR News

Latest METSERA INC (MTSR) News on July 2, 2025

Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?
MTSR

Zacks

7 days ago

Wall Street Analysts See an 89.66% Upside in Metsera Inc. (MTSR): Can the Stock Really Move This High?

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results
MTSR

Insider Monkey

20 days ago

Metsera Unveils First-in-Class Once-Monthly Amylin Candidate MET-233i’s Positive Phase 1 Results

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference
MTSR

GlobeNewswire

22 days ago

Metsera to Present at Goldman Sachs 46th Annual Global Healthcare Conference

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump
MTSR

Investor's Business Daily

22 days ago

Obesity Newcomer Metsera Enters The Ring With A Punch — And A Big Stock Jump

MTSR

MT Newswires

22 days ago

Metsera's Phase 1 Trial of MET-233i Shows Weight Reduction With no Severe Adverse Events

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch
MTSR

Investor's Business Daily

22 days ago

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch

Metsera shares climb on early data for amylin-targeting obesity shot
MTSR

BioPharma Dive

23 days ago

Metsera shares climb on early data for amylin-targeting obesity shot

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i
MTSR

GlobeNewswire

23 days ago

Metsera Announces Positive Phase 1 Data of First-in-Class Once-Monthly Amylin Candidate MET-233i

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®
MTSR

GlobeNewswire

a month ago

Metsera to Present New Research Highlighting the Breadth and Momentum of its Next-Generation Obesity Portfolio at the 85th Scientific Sessions of the American Diabetes Association®

MTSR

MT Newswires

2 months ago

Metsera's Q1 Net Loss Narrows

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress
MTSR

GlobeNewswire

2 months ago

Metsera Reports First Quarter 2025 Financial Results and Continued Portfolio Progress

Metsera to Present at Bank of America 2025 Global Healthcare Conference
MTSR

GlobeNewswire

2 months ago

Metsera to Present at Bank of America 2025 Global Healthcare Conference

MTSR

MT Newswires

3 months ago

Metsera's Q4 Net Loss Widens, Operating Expenses Rise; Shares Higher

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress
MTSR

GlobeNewswire

3 months ago

Metsera Reports Fourth Quarter and Full Year 2024 Financial Results and Continued Portfolio Progress

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month
MTSR

Insider Monkey

4 months ago

Metsera, Inc. (MTSR): Among Top Insider Purchases Last Month

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?
MTSR

Insider Monkey

4 months ago

Is Metsera, Inc. (MTSR) Among Stocks With At Least $20 Million In Insider Spending Recently?

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently
MTSR

Insider Monkey

4 months ago

Metsera, Inc. (MTSR): Among Stocks With At Least $10 Million In Insider Spending Recently

MTSR

Thomson Reuters StreetEvents

4 months ago

Q4 2024 Amneal Pharmaceuticals Inc Earnings Call

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference
MTSR

GlobeNewswire

4 months ago

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference

MTSR

Investing.com

4 months ago

Wall Street bullish on Metsera following January IPO on obesity drug pipeline

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently
MTSR

Insider Monkey

4 months ago

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently

MTSR

MT Newswires

5 months ago

Metsera Closes Initial Public Offering

MTSR

GlobeNewswire

5 months ago

Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares

MTSR

MT Newswires

5 months ago

Metsera Insider Bought Shares Worth $14,219,964, According to a Recent SEC Filing

MTSR

MT Newswires

5 months ago

Metsera Insider Bought Shares Worth $39,999,996, According to a Recent SEC Filing

MTSR

MT Newswires

5 months ago

Metsera Shares Rise Sharply in Nasdaq Debut

MTSR

MT Newswires

5 months ago

Metsera Prices $275 Million IPO

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs
MTSR

Bloomberg

5 months ago

Drugmakers Metsera and Maze Raise Combined $415 Million in IPOs

MTSR

GlobeNewswire

5 months ago

Metsera Announces Pricing of Initial Public Offering

Metsera, Maze secure combined $415 million in IPOs
MTSR

BioPharma Dive

5 months ago

Metsera, Maze secure combined $415 million in IPOs

Share on Social Networks: